Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Moolec Science ( (MLEC) ) has issued an update.
On November 14, 2025, Moolec Science SA received a determination letter from Nasdaq indicating that the company’s ordinary shares had fallen below the minimum $1.00 per share requirement for 30 consecutive business days. Moolec has appealed to a Nasdaq Hearings Panel to request a 180-day period to implement a compliance plan, potentially involving a reverse stock split. The appeal temporarily halts the Nasdaq determination, allowing Moolec’s shares to continue trading under the symbol ‘MLEC’. The company remains focused on addressing the deficiency without impacting its business operations or SEC reporting requirements.
The most recent analyst rating on (MLEC) stock is a Sell with a $3.00 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Underperform.
Moolec Science faces significant financial challenges with negative profitability and cash flow issues despite revenue growth. The technical analysis is bearish, and the valuation appears unfavorable with a negative P/E ratio. These factors contribute to a low overall stock score, highlighting the need for improved financial performance and market sentiment.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science SA operates in the biotechnology industry, focusing on the development of plant-based solutions for the production of animal proteins. The company is engaged in the creation of molecular farming technologies, aiming to address the growing demand for sustainable and efficient protein production.
Average Trading Volume: 194,766
Technical Sentiment Signal: Sell
Current Market Cap: $6.13M
See more data about MLEC stock on TipRanks’ Stock Analysis page.